Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily

ClinicalTrials.gov ID: NCT00634842

Public ClinicalTrials.gov record NCT00634842. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 10, 2026, 4:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effect of Two Different Fasting Blood Glucose Titration Targets in Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily in Combination With 1-3 Oral Agents

Study identification

NCT ID
NCT00634842
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
244 participants

Conditions and interventions

Interventions

  • insulin detemir Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2008
Primary completion
Sep 30, 2008
Completion
Sep 30, 2008
Last update posted
Mar 9, 2017

2008

United States locations

U.S. sites
66
U.S. states
28
U.S. cities
58
Facility City State ZIP Site status
Novo Nordisk Investigational Site Goodyear Arizona 85395
Novo Nordisk Investigational Site Scottsdale Arizona 85251-5638
Novo Nordisk Investigational Site Searcy Arkansas 72143
Novo Nordisk Investigational Site Artesia California 90701
Novo Nordisk Investigational Site Escondido California 92025
Novo Nordisk Investigational Site Fullerton California 92835-3404
Novo Nordisk Investigational Site Los Angeles California 90036
Novo Nordisk Investigational Site Los Angeles California 90057
Novo Nordisk Investigational Site Orange California 92869
Novo Nordisk Investigational Site Spring Valley California 91978
Novo Nordisk Investigational Site Walnut Creek California 94598
Novo Nordisk Investigational Site Parker Colorado 80138-8789
Novo Nordisk Investigational Site Norwalk Connecticut 06851
Novo Nordisk Investigational Site Prospect Connecticut 06712
Novo Nordisk Investigational Site Boca Raton Florida 33433
Novo Nordisk Investigational Site Clearwater Florida 33755-2138
Novo Nordisk Investigational Site Jacksonville Florida 32204
Novo Nordisk Investigational Site Jacksonville Florida 32205
Novo Nordisk Investigational Site Jacksonville Florida 32216
Novo Nordisk Investigational Site Lake Mary Florida 32746
Novo Nordisk Investigational Site Plantation Florida 33324
Novo Nordisk Investigational Site Athens Georgia 30606
Novo Nordisk Investigational Site Roswell Georgia 30076
Novo Nordisk Investigational Site Savannah Georgia 31406
Novo Nordisk Investigational Site Idaho Falls Idaho 83404-7596
Novo Nordisk Investigational Site Chicago Illinois 60607
Novo Nordisk Investigational Site Terre Haute Indiana 47802
Novo Nordisk Investigational Site Topeka Kansas 66606
Novo Nordisk Investigational Site New Orleans Louisiana 70121
Novo Nordisk Investigational Site Pikesville Maryland 21208-3737
Novo Nordisk Investigational Site Saint Paul Minnesota 55108
Novo Nordisk Investigational Site Chesterfield Missouri 63017-3632
Novo Nordisk Investigational Site St Louis Missouri 63141
Novo Nordisk Investigational Site Omaha Nebraska 68114
Novo Nordisk Investigational Site Las Vegas Nevada 89101
Novo Nordisk Investigational Site Berlin New Jersey 08009
Novo Nordisk Investigational Site Camden New Jersey 08104
Novo Nordisk Investigational Site Lawrenceville New Jersey 08648
Novo Nordisk Investigational Site New York New York 10023
Novo Nordisk Investigational Site Staten Island New York 10301
Novo Nordisk Investigational Site West Seneca New York 14224
Novo Nordisk Investigational Site Shelby North Carolina 28152
Novo Nordisk Investigational Site Statesville North Carolina 28625
Novo Nordisk Investigational Site Cincinnati Ohio 45245
Novo Nordisk Investigational Site Dayton Ohio 45406
Novo Nordisk Investigational Site Dayton Ohio 45439
Novo Nordisk Investigational Site Mentor Ohio 44060
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73103
Novo Nordisk Investigational Site Altoona Pennsylvania 16602
Novo Nordisk Investigational Site Norristown Pennsylvania 19401
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19104
Novo Nordisk Investigational Site Spartanburg South Carolina 29303
Novo Nordisk Investigational Site Taylors South Carolina 29687
Novo Nordisk Investigational Site Chattanooga Tennessee 37404
Novo Nordisk Investigational Site Chattanooga Tennessee 37411
Novo Nordisk Investigational Site Arlington Texas 76014
Novo Nordisk Investigational Site Dallas Texas 75231
Novo Nordisk Investigational Site Dallas Texas 75390-9302
Novo Nordisk Investigational Site Houston Texas 77024
Novo Nordisk Investigational Site Houston Texas 77025
Novo Nordisk Investigational Site Midland Texas 79707
Novo Nordisk Investigational Site Odessa Texas 79761
Novo Nordisk Investigational Site San Antonio Texas 78209
Novo Nordisk Investigational Site Spokane Washington 99204-2629
Novo Nordisk Investigational Site Spokane Washington 99218
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00634842, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 9, 2017 · Synced May 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00634842 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →